Next Pharmaceuticals Chairman and Co-Founder, Charles Kosmont Takes Reins as CEO Corporate Offices Move to Salinas, California

Carlsbad, CA – March 26, 2007 – Next Pharmaceuticals (NP) announced today that Charles Kosmont, Chairman and Co-founder has been named CEO of the company. The position was vacated earlier this month due to the sad death of Bob Garrison. NP was founded in 1997 by Garrison and Kosmont, who together built the company to a prominent position in the industry.

“I’m honored to step into Bob’s position and carry on our company’s legacy of being a science-based leader in the industry,” said Kosmont. Before the launch of Next Pharmaceuticals, Charles had successfully managed start-up, rapid growth and turnaround companies. Prior operational positions include: The Met-Rx Companies, President: Vestro Inc., Co-founder and CFO; and Growers Transplanting, Inc., Chairman and CEO. Charles was also a partner in the venture capital firm of Princeton/Montrose Partners. He has extensive practical knowledge of the dietary supplement, herb and photochemical industries.

The corporate offices will be moved from Carlsbad to Salinas, California effective April 4th.
The new contact information will be as follows: Next Pharmaceuticals, 360 Espinosa Road
Salinas, CA 93907, 831-621-8712 phone, 831-621-8745 fax.

Next Pharmaceuticals (NP) was founded with the purpose of developing new, patented, natural ingredients for healthy living products in the dietary supplement, food and beverage industries. The goal of the company is to expand self-care and keep people out of the health care system for a longer period of time. NP has successfully developed six patented plant extracts plus Chromulin™, a new form of the essential trace mineral chromium for potentiating insulin, that have significantly expanded the choices for self-care products while providing large consumer brands with powerful product differentiation. Through the application of pharmaceutical technologies to natural botanical materials, including citrus fruits, NP has developed Relora® for relaxation and stress-related appetite control, Seditol® for better quality of sleep, Nexrutine® for inflammation, Citri-Z® for heart health; Flavoxine™ for healthy cholesterol, and Citrofen™ for mobility and comfort.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.